Mar 01, 2022
Industry and Company News
Announcements in the first quarter of 2022 include our new report that predicts changes to U.S. healthcare during the next decade and the release of three closed claims studies.
From The Doctor’s Advocate

OB Patient Safety Credit Program
We are proud to offer the OB Patient Safety Credit Program, our voluntary program that is open to all qualifying member obstetricians, family practitioners providing obstetrical care, and certified nurse midwives (CNMs) who are actively involved in deliveries.

Jul 28, 2023
Quick Check: Informed Consent Process
Using our Quick Check tool can help you improve your informed consent process and documentation.

New York County Medical Society Renews Exclusive Endorsement With The Doctors Company
The New York County Medical Society (NYCMS) today announced it has again chosen The Doctors Company, part of TDC Group, as the exclusively endorsed medical liability insurer for its members.

Nov 30, 2022
Healthcare Inequities Post-Roe: Clinician Perspectives
Many states with abortion bans are also states with higher proportions of people of color, increasing the uneven impacts of the Dobbs decision, which overturned Roe v. Wade.

Jul 13, 2022
Malpractice May Be Negative, but Its Data Can Generate Positive Results
David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group
We can leverage malpractice data to target and drive investment in patient safety efforts. Malpractice data shows us very clearly that good communication and teamwork are vital to preventing adverse events and malpractice claims—while also dramatically improving working conditions and enhancing patient safety.

Jun 09, 2021
Advocating for a Medical Profession Under Attack
Elizabeth Y. Healy, Assistant Vice President, Government and Community Relations, The Doctors Company
During the first half of 2021, we witnessed a tsunami of legislation and court cases attacking the practice of medicine and medical liability reforms. Too many of these attacks were successful.
From The Doctor’s Advocate

Aug 30, 2021
Preparing for Genomic Medicine: Implications for Medical Practice and Public Policy
Elizabeth Y. Healy, Assistant Vice President, Government and Community Relations, The Doctors Company; Robert Nussbaum, MD, Chief Medical Officer, Chantelle Schenning, PhD, MHA, Head of Public Policy, and Kristine Ashcraft, BS, MBA, Head of Pharmacogenomics, Invitae Corporation
As genomic medicine becomes part of standard clinical care, we learn more about its far-reaching implications on the medical profession, public policy, and the legal system.
From The Doctor’s Advocate

Sep 19, 2022
Industry and Company News
Announcements during the third quarter of 2022 include a new board appointment plus a new product.
From The Doctor’s Advocate

Video Oct 14, 2022

New Thinking About Primary Care and Practice Redesign
Megan Mahoney, MD, MBA, Professor and Chair of the UCSF Department of Family and Community Medicine and member of The Doctors Company Board of Governors, explains how she developed a new model for providing the most efficient and high-quality care in her practice.